InnoCan Pharma Corporation (CSE:INNO) is listed on the Canadian Securities Exchange in the Life Sciences sector, since September 24, 2019. The CSE has covered it in 4 stories and one CSE TV video since 2021.
CSE:INNOCompany profile on thecse.com
Also in these stories: ATL (CSE:ATL), BOIL (CSE:BOIL), PLCN (CSE:PLCN), Cresco Labs Inc. (CSE:CL), CURA (CSE:CURA), IMCC (CSE:IMCC)
This week we take the show on-the-road to Tel Aviv, Israel where we get caught up with tech executives in the health tech, cannabis, life sciences and food tech sectors. First-up is an intro to VVT Medical led by Erez Tetro and Concenter BioPharma, led by Dror Chevion. After introducing their respective businesses Erez and…
(CSE:ATL) and 3 more
Smart drug delivery systems that deliver medications to specific sites in the human body are on the leading edge of science. This type of biomedical engineering focuses on maximizing drug efficiency and minimizing possible side effects, while reducing the overall amount of medication used and frequency of treatment. Cannabinoids play a crucial role in regulating…
InnoCan Pharma Corporation (CSE:INNO)
Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. Since launching just under a decade ago, the agility of the commercial cannabis industry has been nothing short of remarkable. As the global leader in publicly-listed cannabis securities, the Canadian Securities Exchange…
Cresco Labs Inc. (CSE:CL) and 5 more
CSE’s Barrington Miller is joined by Iris Bincovich, CEO of InnoCan Pharma (CSE:INNO) to discuss the company’s focus as a specialty pharmaceutical company including the development of products that harness the unique properties of Cannabinoids combined with smart delivery formulations. The conversation also highlights the importance – and impact – that achieving milestones has had…
InnoCan Pharma Corporation (CSE:INNO)
